Aldoxorubicin will replace doxorubicin on the World Health Organizations list of Essential Medications, and worldwide as the standard of care in low dose chemo
Good Morning, you need to understand that Dr. Patrick Soon Shiong M.D. did not invent Aldoxorubicin: Dr. Felix Kratz PhD did! Aldoxorubicin replaces 5 decades of doxorubicin @mcuban $CYTR $PFE $BMY $JNJ $TSLA $SPCE $SRNE $ACRS $GRTS $JMIA $BLNK $EBON $ETM
https://t.co/1uHGRFFeAb
@drpatrick Pfizer and Moderna can get approval from the FDA in 60 days; you're holding onto and preventing Aldoxorubicin from getting to kids with cancer for 6 years you POS 2017 2018 2019 2020 2021 2022 over 300,000 kids per NIH experience cardio toxicity 50k per year
@drpatrick bullies his competitors and takes advantage of his customers charging $4200 dose for a generic taxol bound to albumin fragments; how much for Aldoxorubicin immunotherapy? what happened to Cynviloq arbitration?
@drpatrick Patrick sure does know basketball, and he sure does know how to bench cancer drugs that would compete with his invention abraxane, but oh wait, he hid Aldoxorubicin for 2017, 2018, 2019, 2020, 2021, 2022 while kids with cancer suffered cardio toxicity !
@elephants_never@drpatrick@drpatrick you benched Aldoxorubicin you are clearly not for cancer patients. Great job protecting abraxane - while 50,000 children with cancer suffer cardio toxicity.
Pat, Kobe is looking down on you . . . get it??
https://t.co/ONzeDUHt8A
@drpatrick Controversy has dogged Soon-Shiong in recent years. NantCell’s acquisition of Altor BioScience spawned lawsuits, including a case brought by Cher, and accusations of “looting.”
@drpatrick Precision Biologics shareholder argued the withdrawal breached an investor rights agreement and the fiduciary duties of Soon-Shiong and his co-defendants.
@drpatrick is there inflation? Does death lose its sting? Is your mommy and daddy proud of you? Oct 1, 2006 — CHARGING $4,200 a dose for a new version of an old cancer drug has helped make Dr. Patrick Soon-Shiong a billionaire.
Hope, at $4,200 a Dose - The New York Times
@drpatrick how did you get your name on the Aldoxorubicin patent so quickly?
https://t.co/Uw7vjY4n7C
Did you get permission from Celgene? Bristol Myers becsuse this would interfere with the Non Compete agreement
@drpatrick deal with $cytr for cancer drug Aldoxorubicin is like the @Lakers buying player Kobe Bryant contract and the BENCHING him 2017, 2018, 2019, 2020 2021 2022 so he cant compete
@elephants_never@drpatrick@Lakers did you read this one doc? Would you hire KOBE Bryant - then bench him for 7 years 2017, 2018, 2019, 2020, 2021, 2022 like you did with Aldoxorubicin while according to NIH 50,000 children per year w cancer experience cardiotoxicity - File the New Drug Application Aldoxorubicin
@ontrack9_oktogo@drpatrick@drpatrick is a champion pioneer for cancer patients, especially kids with cancer; unless of course it's a superior generic abraxane modality like $srne 's Cynviloq or Albumin bound dox like $cytr's Aldoxorubicin then soon shiong says $$$$$ is more important than patients